共 7 条
[1]
Hemodynamic impact of thrombolytic therapy in acute pulmonary thromboembolism. Bauzzi AC,Knobel E,Cirenza C,et al. Arquivos Brasileiros de Cardiologia . 1995
[2]
Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. Konstantinides S,Geibel A,Heusel G,et al. The New England Journal of Medicine . 2002
[3]
Local and systemic thrombolytic therapy for acute venous thromboembolism. Arcasoy SM,Vachani A. Chest Med . 2003
[4]
Coronary thrombolisis with recombinant human tissue type plasminogen activator: A prospective , randomized, placebo controlled trial. Collen D,Topol E J. Circulation . 1999
[5]
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: an uropean multicenter double blind trial. Meyer G,Sors H,Charbonnier B,et al. Journalism Assn of Community College . 1992
[6]
Long- term benefit of thrombolytic therapy in patients with pulmonary embolism. Sharma GV,Folland ED,McIntyre KM,et al. Vascular Medicine . 2000
[7]
Mechanical and enzymatic thrombolysis for massive pulmonary embolism. De Greorio MA,Gimeno M J,Mainar A,et al. Journal of Vascular and Interventional Radiology . 2002